Skip to main content

Research Repository

Advanced Search

Risk of bleeding with direct oral anticoagulants versus warfarin: cohort studies using primary care datasets

Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia

Authors

CAROL COUPLAND carol.coupland@nottingham.ac.uk
Professor of Medical Statistics

Julia Hippisley-Cox



Abstract

Background: There is limited evidence on the safety of direct oral anticoagulants (DOACs) in real world settings.

Aim: To investigate risks of bleeding and all-cause mortality in DOACs compared to warfarin.

Method: Prospective cohorts of incident oral anticoagulant users between 2011 and 2016 derived from two UK databases (QResearch and CPRD) linked to hospital and mortality data, with no anticoagulant prescriptions in the year before entry, were selected. Overall, 132,231 warfarin, 7744 dabigatran, 37,863 rivaroxaban, and 18,223 apixaban users, were sub-grouped into those with atrial-fibrillation (AF) and without (non-AF), followed up until any major bleed leading to hospital admission or death. Analyses were adjusted for demographics, life style, comorbidities and prescribed medications.

Results: Compared to warfarin, apixaban was associated with decreased risk of major bleeding (hazard ratio 0.62, 95% confidence interval [CI] = 0.54 to 0.73), intracranial (HR 0.48, 95% CI = 0.34 to 0.68) and gastro-intestinal (HR 0.67, 95% CI = 0.54 to 0.83). Dabigatran and rivaroxaban were associated with decreased risk of intracranial bleeding (HR 0.44, 95% CI = 0.27 to 0.71; HR 0.73, 95% CI = 0.59 to 0.90). Rivaroxaban was associated with increased risk of all-cause mortality (HR 1.34, 95% CI = 1.26 to 1.42), consistent for both sub-cohorts. A small increased all-cause mortality risk for apixaban (HR 1.14, 95% CI = 1.05 to 1.24) was statistically significant on the lower doses (HR 1.31, 95% CI = 1.19 to 1.45) but not on higher doses (HR 0.98, 95% CI = 0.87 to 1.10).

Conclusion: Overall, apixaban was found to be the safest drug for any major bleed, particularly for patients with increased risk of intracranial or gastro-intestinal bleeding.

Citation

Vinogradova, Y., Coupland, C., Hill, T., & Hippisley-Cox, J. (2018). Risk of bleeding with direct oral anticoagulants versus warfarin: cohort studies using primary care datasets. British Journal of General Practice, 68(suppl 1), doi:10.3399/bjgp18X696629

Journal Article Type Article
Acceptance Date May 1, 2018
Online Publication Date Jun 6, 2018
Publication Date 2018-06
Deposit Date Nov 28, 2018
Publicly Available Date Nov 28, 2018
Journal British Journal of General Practice
Print ISSN 0960-1643
Electronic ISSN 1478-5242
Publisher Royal College of General Practitioners
Peer Reviewed Peer Reviewed
Volume 68
Issue suppl 1
Article Number bjgp18X696629
DOI https://doi.org/10.3399/bjgp18X696629
Public URL https://nottingham-repository.worktribe.com/output/1221624
Publisher URL https://bjgp.org/content/68/suppl_1/bjgp18X696629